102 related articles for article (PubMed ID: 6880125)
1. [Opportunities for the evaluation of the secondary reaction of antituberculosis drugs by several indicators, determined in the blood of patients with tuberculosis of the lungs].
Khomenko AG; Vysochina IV; Kolosovskaia VP; Efimova LN; Kuz'mina NV
Vopr Med Khim; 1983; 29(3):83-8. PubMed ID: 6880125
[TBL] [Abstract][Full Text] [Related]
2. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
Panova LV; Ovsiankina ES
Probl Tuberk; 2003; (1):28-30. PubMed ID: 12652980
[TBL] [Abstract][Full Text] [Related]
3. [Erythrocyte metabolism during chemotherapy in pulmonary tuberculosis patients].
Kaminskaia GO; Abdullaev RIu
Probl Tuberk; 1993; (6):32-5. PubMed ID: 8290528
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of tuberculosis].
Eier A; Grass S
Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
[TBL] [Abstract][Full Text] [Related]
5. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
[TBL] [Abstract][Full Text] [Related]
6. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
Borisova MI; Stakhanov VA; Sharkova TI; Ivashchenko NA
Probl Tuberk Bolezn Legk; 2003; (7):34-7. PubMed ID: 12939876
[TBL] [Abstract][Full Text] [Related]
7. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koula-Shiro S
Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
[TBL] [Abstract][Full Text] [Related]
8. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
9. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
10. [Side effects of antibacterial drugs in patients with fibro-cavitary tuberculosis of the lungs].
Butenko GE
Probl Tuberk; 1972; 50(3):33-6. PubMed ID: 5037239
[No Abstract] [Full Text] [Related]
11. Current recommendations of chemotherapy and pharmacology of antituberculosis drugs.
Bhattacharyya P
J Indian Med Assoc; 2000 Mar; 98(3):119-22, 129. PubMed ID: 11016167
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the effects of antituberculous drugs on the cytochemical status of lymphocytes in vitro].
Vasil'eva OA; Urazova OI; Serebriakova VA; Novitskiĭ VV; Strelis AK; Shevtsova NM; Voronkova OV; Mel'nik MI; Khasanova RR
Probl Tuberk Bolezn Legk; 2008; (3):27-30. PubMed ID: 18450076
[TBL] [Abstract][Full Text] [Related]
13. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
14. [Side reactions, drug intolerance in antibacterial therapy and the state of the enzyme system, vascular permeability in patients with pulmonary tuberculosis].
Fuks PM; Kononova II
Sov Zdravookhr Kirg; 1970; 3():18-21. PubMed ID: 5492364
[No Abstract] [Full Text] [Related]
15. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
Chukanov VI; Kaminskaia GO; Livchane E
Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI
Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of side effects during chemotherapy of tuberculosis].
Eĭnis VL; Tuganova VE
Probl Tuberk; 1970; 48(6):18-22. PubMed ID: 5447927
[No Abstract] [Full Text] [Related]
18. [Changes in the patients' mental status in the tolerability of antituberculous drugs].
Mordyk AV; Briukhanova NS; Kazakov AV
Probl Tuberk Bolezn Legk; 2009; (3):38-42. PubMed ID: 19455986
[TBL] [Abstract][Full Text] [Related]
19. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].
Ubaĭdullaev AM; Tashpulatova FK; Kazakov KS
Probl Tuberk; 1998; (4):23-4. PubMed ID: 9771032
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
